NeuroSense Therapeutics Ltd. Weighted Average Share Price Share Options Granted2019
NeuroSense Therapeutics Ltd. (NRSN) reported Weighted Average Share Price Share Options Granted2019 of $3.72 per share for the 12-month period ending 2021-12-31, per its 20-F filed 2022-04-14.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2022-04-14
| Period end | Weighted Average Share Price Share Options Granted2019 12 month |
|---|---|
| 2021-12-31 | $3.72 20-F · filed 2022-04-14 |